Human LDH (Plasmodium vivax)

Slide this table

Size25 µg
Price490 €
CategoryCytokines & Growth Factors
SourceInsect cells
Species ReactivityHuman
Purity Confirmation> 80% by SDS-PAGE & Coomassie stain
Length [aa]319
Molecular Weight35 kDa
Buffer50 mM Tris, 250 mM NaCl, 1 mM EDTA
Stability and StorageAccording to the available data the liquid protein stored at 4-8°C is stable at least for about 10 months.
ApplicationStandard for ELISA
Synonymslactate dehydrogenase
DescriptionMalaria is one of the most widespread infectious diseases affecting some 500 million people with an enormous cost in human suffering and economic hardship. Effective treatment of the disease is increasingly compromised by rising resistance of malaria parasites to currently available anti-malarials. The parasites are homolactate fermenters and rely on glycolysis for energy generation since the parasites appear to lack a functional citric acid cycle. The NAD+ consumed during glycolysis is reduced to NADH by lactate which, in turn, is oxidized to pyruvate. This reaction is catalyzed by lactate dehydrogenase (LDH). It has been demonstrated that inhibitors of this enzyme have parasiticidal activity. Since LDH from the malaria parasite Plasmodium falciparum (PfLDH) has notable structural and kinetic differences from human LDHs, the enzyme appears to be an attractive target for novel anti-malarial therapeutics. The parasite, P. falciparum, is the most lethal of malarial plasmodia being responsible for the cerebral form of the disease; consequently it has been the major focus of initial biochemical and genomic investigation. On the other hand, the parasite P. vivax is of great importance as it is the most widespread and common of the malarial plasmodia and, therefore, is responsible for the greatest burden of disease.
Uniprot IDQ4PRK9
Protein RefSeqAEP83561.1
mRNA RefSeqJN547220.1

All prices plus VAT + possible delivery charges